Local Radiation Treatment of HER2-Positive Breast Cancer Using Trastuzumab-Modified Gold Nanoparticles Labeled with 177Lu. (Q52775601)

7 May 2018

title

Local Radiation Treatment of HER2-Positive Breast Cancer Using Trastuzumab-Modified Gold Nanoparticles Labeled with 177Lu. (English)

1 reference

7 May 2018

1 reference

5

Mitchell A Winnik

1 reference

7 May 2018

7

Raymond M Reilly

1 reference

7 May 2018

author name string

Zhongli Cai

1

1 reference

7 May 2018

Simmyung Yook

2

1 reference

7 May 2018

Yijie Lu

3

1 reference

7 May 2018

Dane Bergstrom

4

1 reference

7 May 2018

Jean-Philippe Pignol

6

1 reference

7 May 2018

publication date

16 December 2016

1 reference

7 May 2018

published in

Pharmaceutical Research

1 reference

7 May 2018

volume

34

1 reference

7 May 2018

issue

3

1 reference

7 May 2018

page(s)

579-590

1 reference

7 May 2018

Long-term effects of mammography screening: updated overview of the Swedish randomised trials

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2082-2

Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2082-2

Definition and consequences of locally advanced breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2082-2

Update on locally advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2082-2

Surgery following neoadjuvant therapy in patients with HER2-positive locally advanced or inflammatory breast cancer participating in the NeOAdjuvant Herceptin (NOAH) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2082-2

Preoperative concurrent paclitaxel-radiation in locally advanced breast cancer: pathologic response correlates with five-year overall survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2082-2

Neoadjuvant interstitial high-dose-rate (HDR) brachytherapy combined with systemic chemotherapy in patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2082-2

Intratumorally Injected 177Lu-Labeled Gold Nanoparticles: Gold Nanoseed Brachytherapy with Application for Neoadjuvant Treatment of Locally Advanced Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2082-2

Impact of breast cancer molecular subtypes on locoregional recurrence in patients treated with neoadjuvant chemotherapy for locally advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2082-2

Epidermal growth factor receptor in triple-negative and basal-like breast cancer: promising clinical target or only a marker?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2082-2

Radiation Nanomedicine for EGFR-Positive Breast Cancer: Panitumumab-Modified Gold Nanoparticles Complexed to the β-Particle-Emitter, (177)Lu.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2082-2

Prognostic impact of human epidermal growth factor-like receptor 2 and hormone receptor status in inflammatory breast cancer (IBC): analysis of 2,014 IBC patient cases from the California Cancer Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2082-2

Associations between the uptake of 111In-DTPA-trastuzumab, HER2 density and response to trastuzumab (Herceptin) in athymic mice bearing subcutaneous human tumour xenografts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2082-2

Optimized digital counting colonies of clonogenic assays using ImageJ software and customized macros: comparison with manual counting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2082-2

Utility of γH2AX as a molecular marker of DNA double-strand breaks in nuclear medicine: applications to radionuclide therapy employing auger electron-emitting isotopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2082-2

Computational analysis of the number, area and density of gamma-H2AX foci in breast cancer cells exposed to (111)In-DTPA-hEGF or gamma-rays using Image-J software

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2082-2

Controlled internalization of Her-2/ neu receptors by cross-linking for targeted delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2082-2

Bioorthogonal, two-component delivery systems based on antibody and drug-loaded nanocarriers for enhanced internalization of nanotherapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2082-2

Nanoparticle-mediated cellular response is size-dependent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2082-2

Molecularly targeted gold nanoparticles enhance the radiation response of breast cancer cells and tumor xenografts to X-radiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2082-2

Laminin receptor specific therapeutic gold nanoparticles (198AuNP-EGCg) show efficacy in treating prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2082-2

Doses to internal organs for various breast radiation techniques--implications on the risk of secondary cancers and cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2082-2

Depot system for controlled release of gold nanoparticles with precise intratumoral placement by permanent brachytherapy seed implantation (PSI) techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2082-2

Overview on locally advanced breast cancer: defining, epidemiology, and overview on neoadjuvant therapy

21 January 2018

1 reference

12 December 2020

Primary chemotherapy in breast cancer: correlation between tumor response and patient outcome

1 reference

12 December 2020

Clinical and pathological response to primary chemotherapy in patients with locally advanced breast cancer grouped according to hormonal receptors, Her2 status, grading and Ki-67 proliferation index.

1 reference

12 December 2020

Molecular targeting radiotherapy with cyclo-RGDFK(C) peptides conjugated to 177Lu-labeled gold nanoparticles in tumor-bearing mice

1 reference

12 December 2020

Role of antibody-mediated tumor targeting and route of administration in nanoparticle tumor accumulation in vivo.

1 reference

12 December 2020

Breast cancer subtypes based on ER/PR and Her2 expression: comparison of clinicopathologic features and survival

1 reference

12 December 2020

10.1007/S11095-016-2082-2

Identifiers

DOI

1 reference

7 May 2018

PubMed ID

27987070

1 reference

7 May 2018